Benserazide Hydrochloride

Benserazide Hydrochloride API (CAS No: 14919-77-8) is produced at Amber Lifesciences Pvt. Ltd. in GMP-compliant and ISO 9001:2015 certified facilities, ensuring exceptional purity, batch-to-batch consistency, and global regulatory compliance. Each batch is supplied with a detailed Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS), meeting the specifications of USP/EP pharmacopeial standards.

Benserazide Hydrochloride is a peripheral aromatic L-amino acid decarboxylase inhibitor used in combination with Levodopa for the management of Parkinson’s disease. By inhibiting peripheral metabolism of Levodopa, it increases its availability to the central nervous system, enhancing therapeutic efficacy. Our API is produced under stringent quality control procedures to guarantee reliability and performance in pharmaceutical formulations.

Amber Lifesciences serves pharmaceutical manufacturers, shippers, traders, distributors, and formulation partners across Asia, Europe, the Middle East, and LATAM regions, offering reliable supply chains, technical support, and complete regulatory documentation to ensure efficient product registration and market access. 

Storage & Transportation

Classified as non-Dangerous Goods. Store at a controlled room temperature (20°C to 25°C / 68°F to 77°F), protected from moisture and light. Standard pharmaceutical handling precautions should be followed during storage and transportation.